The International Chamber of Commerce, representing a vast network of businesses across diverse sectors and global regions, has formally expressed its appreciation for the Friends of the Cali Fund initiative and its recent declaration, signaling a pivotal moment in the intersection of global commerce and environmental stewardship. In a comprehensive statement, the ICC welcomed the initiative’s explicit recognition of the necessity for private sector collaboration to overcome existing barriers to the implementation of a multilateral benefit-sharing mechanism. The business community, through the ICC, has declared its readiness to engage deeply with the initiative, alongside other Parties and stakeholders, to construct the foundational conditions required for a coherent, effective, and workable system that meaningfully supports global biodiversity goals. This move comes at a critical juncture as the international community seeks to operationalize the Kunming-Montreal Global Biodiversity Framework, specifically regarding the complex and often contentious issue of Digital Sequence Information on genetic resources.
The Emergence of the Cali Fund and the DSI Debate
The "Cali Fund" represents a landmark achievement in international environmental diplomacy, established during the 16th Conference of the Parties (COP16) to the Convention on Biological Diversity (CBD), held in Cali, Colombia. The fund is designed to act as a global repository for financial contributions arising from the use of Digital Sequence Information (DSI). DSI refers to the digitized genetic blueprints of plants, animals, and microbes, which are stored in massive, publicly accessible databases. These sequences are the lifeblood of modern biotechnology, enabling the development of everything from life-saving vaccines and advanced antibiotics to drought-resistant crops and sustainable cosmetics.
Historically, the CBD and its Nagoya Protocol operated on a bilateral basis: if a company used a physical genetic resource from a specific country, it negotiated a benefit-sharing agreement with that country. However, the digital revolution has rendered physical borders less relevant. Scientists can now access genetic data online without ever touching a physical specimen. This "de-materialization" of genetic resources created a loophole where the benefits derived from biodiversity were not being returned to the biodiversity-rich nations—often in the Global South—that preserved those resources. The Cali Fund aims to close this gap through a multilateral mechanism, collecting contributions from commercial users of DSI and redistributing them to support conservation efforts and Indigenous peoples.
A Chronology of Global Biodiversity Governance
The path to the Cali Fund has been defined by decades of evolving legal frameworks and shifting scientific paradigms. Understanding the ICC’s current stance requires a look at the timeline that brought the international community to this point:
- 1992: The Rio Earth Summit. The Convention on Biological Diversity is opened for signature, establishing three main goals: the conservation of biological diversity, the sustainable use of its components, and the fair and equitable sharing of benefits arising from genetic resources.
- 2010: The Nagoya Protocol. Adopted to provide a legal framework for the third goal of the CBD. However, it focused primarily on physical genetic resources, leaving the emerging field of DSI in a legal gray area.
- 2022: COP15 and the Kunming-Montreal Global Biodiversity Framework (GBF). After years of delay due to the pandemic, nations agreed on a historic plan to halt and reverse biodiversity loss by 2030. Decision 15/9 was a cornerstone of this agreement, establishing a process to create a multilateral mechanism for benefit-sharing from DSI.
- 2024: COP16 in Cali. The "Cali Fund" is officially conceptualized. The Friends of the Cali Fund, a coalition of proactive governments and entities, began advocating for a system that is both ambitious in its funding goals and practical in its execution.
- Present Day: The ICC’s formal response marks the beginning of a technical negotiation phase, where the "how" of the fund—its governance, triggers for payment, and distribution metrics—will be decided.
The Business Perspective: Value, Conservation, and Legal Certainty
The ICC’s endorsement of the Cali Fund is predicated on the recognition that nature is not merely an externalized resource but the very foundation of economic value. Modern industries—ranging from pharmaceuticals and agriculture to energy and materials science—are intrinsically linked to the health of global ecosystems. The ICC statement emphasizes that the multilateral mechanism represents a unique opportunity to streamline and facilitate the sharing of benefits. By moving away from a patchwork of inconsistent national regulations toward a unified global system, the private sector hopes to reduce administrative burdens and increase transparency.
However, the business community’s support is not unconditional. The ICC has highlighted that joint efforts are needed to ensure the mechanism aligns with Paragraph 9 of CBD Decision 15/9. This specific mandate requires that the mechanism be "efficient, open, and provide clarity and legal certainty." For a global corporation, legal certainty is paramount. Without clear rules on who must pay, how much, and under what circumstances, businesses face the risk of retrospective claims, double-charging by different jurisdictions, and significant "economic distortion" that could stifle research and development.
Supporting Data: The Economic Stakes of DSI
The scale of the industries reliant on DSI underscores why the ICC is so invested in the outcome of these negotiations. According to various economic assessments:
- The Pharmaceutical Sector: Global pharmaceutical revenue reached approximately $1.6 trillion in 2023. A significant portion of new drug discovery involves the screening of genetic sequences.
- Agricultural Biotechnology: The global market for seeds and agricultural biotech is valued at over $100 billion. The development of climate-resilient crops is almost entirely dependent on the free flow of DSI.
- The Cosmetics and Personal Care Industry: This sector, valued at over $500 billion globally, increasingly relies on "natural" active ingredients derived from genetic research.
- The Funding Gap: The United Nations estimates a $700 billion annual deficit in biodiversity funding. The Cali Fund is eyed as a critical tool to bridge this gap, with some proponents suggesting that even a 0.1% or 1% contribution from DSI-dependent sectors could generate billions of dollars annually for conservation.
The ICC argues that for these contributions to be sustainable, the mechanism must be proportionate. If the financial burden is too high, it could disincentivize companies from using DSI altogether or drive innovation into secretive, non-public databases, which would be detrimental to the global scientific community and the principle of "open science."
Addressing Implementation Barriers and Governance Issues
The ICC’s statement explicitly mentions the need to address "remaining important conceptual, governance, and practical implementation issues." These issues are the primary hurdles that negotiators face in the coming months.
One of the most significant conceptual challenges is defining the "trigger" for payment. Should a company pay a percentage of its total revenue, or only revenue derived from a specific product that utilized a specific sequence? Furthermore, how does one track the use of a sequence that has been modified thousands of times through synthetic biology? The ICC advocates for a system that avoids complex tracking and tracing, which would be technologically impossible and prohibitively expensive. Instead, a "revenue-based" approach at the corporate level is often discussed as a more "workable" alternative.
Governance is another point of contention. The ICC and its members are seeking assurance that the funds collected will be managed transparently and used effectively for biodiversity conservation. There is a strong call for the private sector to have a seat at the table in the fund’s governance structure to ensure that the distribution of benefits is data-driven and yields measurable environmental outcomes.
Official Responses and Inferred Stakeholder Reactions
While the ICC represents the global business voice, other stakeholders have expressed varying degrees of optimism and caution. Developing nations, represented often by the G77 and China, have historically pushed for mandatory, high-percentage contributions to ensure "equity." They argue that the "voluntary" nature of some proposed models might fail to generate the necessary funds.
In contrast, many scientific organizations and academic institutions share the ICC’s concern regarding the "open access" of data. They fear that any mechanism that places a "price tag" on accessing databases like GenBank or the European Nucleotide Archive could slow down the rapid sharing of data necessary to combat global health crises, such as future pandemics.
The ICC’s move to "stand ready to engage" is seen by analysts as a strategic effort to bridge these divides. By positioning business as a partner rather than an opponent, the ICC aims to shape a mechanism that satisfies the ethical demands of the Global South while maintaining the economic incentives for innovation in the Global North.
Broader Impact and the Path Toward COP17
The success of the Cali Fund and the multilateral mechanism will likely determine the overall success of the Kunming-Montreal Global Biodiversity Framework. If the mechanism is effective, it could provide a steady stream of "nature-positive" investment, empowering Indigenous communities—who are the primary guardians of the world’s remaining biodiversity—and funding large-scale restoration projects.
For the private sector, a successful mechanism would offer a "social license to operate." In an era of increasing ESG (Environmental, Social, and Governance) scrutiny, companies that contribute to the Cali Fund can demonstrate a tangible commitment to the preservation of the natural capital upon which their business models depend.
Looking forward, the ICC will participate in a series of technical expert group meetings and intersessional negotiations leading up to COP17. The focus will remain on ensuring that the final proposals are "workable in practice for all concerned." The goal is a coherent benefit-sharing landscape where national laws and international instruments are aligned, preventing a fragmented regulatory environment that would only serve to hinder both commerce and conservation.
As the ICC statement concludes, the priority is to move toward a mechanism that is effective in its contribution to biodiversity goals and grounded in the realities of modern research and innovation. The coming years will reveal whether this collaborative spirit between the private sector and international regulators can truly create a sustainable financial model for the protection of the planet’s biological heritage.
About the Author
